Softgel

Global Diet Pills Market Forecast Report 2021-2028: Increase in Self-care to Drive Market Growth & Shift Toward Plant-Based Supplements - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 28, 2022
Fitness & Nutrition, Health, Distribution, Novo Nordisk, TEVA, Awareness, Capsule, Obesity, GlaxoSmithKline, Moran v. Household International, Inc., Tablet, Union, Softgel, COVID-19, Overweight, BMI, Weight loss, Health, Body mass index, Woman, Dietary supplement, Ageing, CAGR, Research, Pfizer, Industry, Profile, Population, Man, Pharmaceutical industry, EU

The "Diet Pills Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, Age Group and Distribution Channel" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Diet Pills Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, Age Group and Distribution Channel" report has been added to ResearchAndMarkets.com's offering.
  • The increase in self-care, the rising problem of obesity, an increase in the elderly population, and a surge in women taking dietary supplements are driving the diet pills market.
  • However, the challenging regulatory environment is expected to restrict the market growth during the forecast period.
  • Thus, with the rising obesity rate, the demand for diet pills and supplements has increased.

Panacea Life Sciences Holdings, Inc. Announces Participation in Investor Summit Group's Q2 In-Person Conference

Retrieved on: 
Tuesday, April 19, 2022
Consumer, Softgel, Sleep, Pain, Communication services sector reshuffle, Real estate, Research, Human, Sale, Patient, Conference, OTCQB, Complimentary, CGMP, Animal, Summit Group, FDA, Epilepsy, Cancer, Pharmaceutical industry, Technology, Finance, Health care

Please register at Complimentary Investor Registration

Key Points: 
  • Please register at Complimentary Investor Registration
    About Panacea Life Sciences Holdings, Inc.
    Panacea Life Sciences Holdings, Inc. (OTCQB:PLSH) is a fully integrated FDA, cGMP certified, seed-to-sale cannabinoid product focused company.
  • We have expanded our research and development preclinical and clinical programs, with a focus on nutraceutical and purposeful, natural pharmaceutical alternatives for humans and companion animals.
  • The Investor Summit Group (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors.
  • The Q2 Investor Summit Group will take place in-person, featuring 65+ companies and over 300 investors comprising institutional investors, family offices, and high net worth investors.

Trust Transparency Center Rewards Best in Class Supplement Contract Manufacturing

Retrieved on: 
Tuesday, April 12, 2022
Softgel, CEO, Auston Trusty, ITC, Association, Tablet, Printing, Database, Capsule, Leadership, Gemini, Growth, Technology, TTC, FDA, Industry, Partnership, Global, Cryptocurrency, Dietary supplement

SPRING, Texas, April 12, 2022 /PRNewswire/ -- Today, Trust Transparency Center (TTC), the strategy and insights firm serving the dietary supplement and natural products industry, announced the winners of its first annual TRUSTYs awards. The TRUSTYs award is the culmination of efforts by Trust Transparency Center to develop a database of contract manufacturer capabilities, expertise, and their track record in market. The 2022 'Traditional Format' award is going to Gemini Pharmaceuticals, and Smart Cups won for the 'Novel Format' category.

Key Points: 
  • The TRUSTYs award is the culmination of efforts by Trust Transparency Center to develop a database of contract manufacturer capabilities, expertise, and their track record in market.
  • "One area that has traditionally been opaque and non-differentiated is contract manufacturing and manufacturing services and we at TTC are committed to providing transparency and differentiating tools.
  • "Gemini Pharmaceuticals is deeply honored to be chosen by Trust Transparency Center as the first ever recipient of their Traditional Contract Manufacturers Award.
  • We are grateful to be recognized as innovators and best in class by the Trust Transparency Center."

Makers Nutrition Donates for Peaceful Easter, Passover, Springtime Meals

Retrieved on: 
Tuesday, April 5, 2022
Parent, Friends, BBB, Softgel, Charity Navigator, Organic, Tablet, New York metropolitan area, Efficiency, Powder, Capsule, Food, Table, Toy

HAUPPAUGE, N.Y., April 5, 2022 /PRNewswire-PRWeb/ -- No stranger to the support Friends of Karen provides children with life-threatening illnesses and their families, Makers Nutrition has gifted the organization financially so that parents of these children are not faced with the challenge of choosing between paying bills and providing a wholesome holiday dinner.

Key Points: 
  • With everything that is going on in the world, both at home and abroad, Makers Nutrition knew it wanted to sprinkle some serenity on families who could use a helping hand this spring season.
  • As a leading vitamin and supplement manufacturing provider in the nutraceutical industry, the Makers Nutrition team takes pride in having the ability to make a positive impact in the area in which it specializes mostnutrition.
  • A two-time Inc. 5000 honoree, Makers Nutrition is a groundbreaking provider for dietary supplement companies worldwide.
  • Specializing in capsules, tablets, powders, softgels and gummies, Makers Nutrition provides a full-service option for all contract manufacturing, graphic design, packaging, and fulfillment service needs.

Pharvaris Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights

Retrieved on: 
Tuesday, March 29, 2022
Administration, Colon, Mission statement, Degenerative disease, Record, Investment, Book, PK, International Accounting Standards Board, Softgel, Attack, Pharmacokinetics, Skin, Bradykinin, CSO, Research, U.S. Securities and Exchange Commission, Board of directors, HAE, Security (finance), G&A, Industry, International, COVID-19, Intellectual property, GLOBE, Șaeș, EC50, Union, Hereditary angioedema, R, Annual report, FDA, Research and development, Food, Patient, IFRS, Pharmaceutical industry, Vaccine, Dietary supplement

R&D expenses were 10.7 million for the fourth quarter and 35.8 million for the full year of 2021, compared to 7.7 million for the fourth quarter and 19.5 million for the full year of 2020.

Key Points: 
  • R&D expenses were 10.7 million for the fourth quarter and 35.8 million for the full year of 2021, compared to 7.7 million for the fourth quarter and 19.5 million for the full year of 2020.
  • G&A expenses were 5.5 million for the fourth quarter and 18.3 million for the full year of 2021, compared to 2.1 million for the fourth quarter and 5.5 million for the full year of 2020.
  • Loss for the fourth quarter was 12.3 million, resulting in basic and diluted loss per share of 0.41.
  • Pharvaris is a Foreign Private Issuer and prepares and reports consolidated financial statements and financial information in accordance with IFRS as issued by the International Accounting Standards Board.

ZYUS Life Sciences Awarded EU-GMP Certification, Enables Expansion into Rapidly Growing Global Medical Cannabinoids Markets

Retrieved on: 
Wednesday, March 9, 2022
Biotechnology, Alternative Medicine, Health, Other Health, Well, Industry, Clinical trial, 2006–2007 economic sanctions against the Palestinian National Authority, Documentation, Medication, Public health, Softgel, News, Cannabinoid, Patient, Â, Science, Union, IP, Certification, Terminology, Forward-looking statement, Pharmaceutical industry, Risk management, EU

ZYUS’ EU-GMP certification was granted by Portugal’s Infarmed -- National Authority of Medicines and Health Products, I.P. -- that evaluates, authorizes, and regulates medicines and medical devices for the protection of public health. Infarmed pursues its activity in several domains at national and European levels, and during its extensive audit of ZYUS’ industry leading, pharmaceutical-grade cannabinoid extraction facility, ZYUS demonstrated that its leading-edge Canadian site together with its manufacturing facilities and extensive processes and documentation consistently met or exceeded the stringent EU-GMP certification requirements as a medicines manufacturer.

Key Points: 
  • ZYUS Life Sciences Inc. ("ZYUS"), a Canadian-based life sciences company leading scientific research and development in phyto-therapeutics, announced today that the companys Canadian manufacturing facility has been awarded EU-Good Manufacturing Practice (EU-GMP) certification.
  • ZYUS has already established multiple pharmaceutical distribution and sales arrangements to supply medical cannabinoids across several international markets.
  • Receipt of this certification marks an important step in ZYUS journey to improve a growing number of patient outcomes, and another milestone in the companys global expansion.
  • About ZYUS Life Sciences Inc.
    ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates.

Global Dietary Supplements Markets, 2021-2028: COVID-19 Impact and Analysis By Type (Vitamins, Minerals, Proteins and Amino Acids, Probiotics, Blends) & Form (Tablets, Capsules and Softgels, Powders) - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 2, 2022
Fitness & Nutrition, Health, Bayer, Animal, Tablet, Organic acid, Dietary supplement, GlaxoSmithKline, Enzyme, Capsule, Health, Bacteria, Market share, Nutrient, US, Vitamin, COVID-19, Pfizer, Extrapyramidal system, Bountiful, In re Amway Corp., Geography, CAGR, Protein, Amino acid, Indigestion, Pain scale, Distribution, Human, Softgel, Powder, Mineral, Form, Probiotic

Dietary supplements contain dietary ingredients to improve their nutritional worth.

Key Points: 
  • Dietary supplements contain dietary ingredients to improve their nutritional worth.
  • Dietary supplements consist of various nutrients, such as vitamins, minerals, proteins, amino acids, and probiotics.
  • Based on type, the dietary supplements market is segmented into vitamins, minerals, proteins and amino acids, probiotics, blends, and others.
  • ; and The Bountiful Company are among the key players operating in the dietary supplements market.

New THC & CBD Brand Launches Line Of THC Seltzers Across the US

Retrieved on: 
Wednesday, February 23, 2022
Lazarus, Fear, Boredom, Energy drink, Partnership, CBD, Perception, Pesticide, Uncertainty, Softgel, Beer, The Non-GMO Project, THC, Drink, Anxiety, Knowledge, Cannabis, Entertainment, Soft drink, Drug, Tourism

Based out of Seattle, Washington, Cycling Frog announced its entry into the legal cannabis beverage market with a new lineup of THC seltzers to rival booze.

Key Points: 
  • Based out of Seattle, Washington, Cycling Frog announced its entry into the legal cannabis beverage market with a new lineup of THC seltzers to rival booze.
  • They also have a range of THC & CBD gummies, softgels, and mints available to buy online.
  • Jason Peterson, Head of Brand, says, "We're delighted to launch Cycling Frog and our THC & CBD seltzers.
  • "With our products, we're hoping to change an entire generation's perception and access to THC & CBD products.

New THC & CBD Brand Launches Line Of THC Seltzers Across the US

Retrieved on: 
Wednesday, February 23, 2022
Lazarus, Fear, Boredom, Energy drink, Partnership, CBD, Perception, Pesticide, Uncertainty, Softgel, Beer, The Non-GMO Project, THC, Drink, Anxiety, Knowledge, Cannabis, Entertainment, Soft drink, Drug, Tourism

Based out of Seattle, Washington, Cycling Frog announced its entry into the legal cannabis beverage market with a new lineup of THC seltzers to rival booze.

Key Points: 
  • Based out of Seattle, Washington, Cycling Frog announced its entry into the legal cannabis beverage market with a new lineup of THC seltzers to rival booze.
  • They also have a range of THC & CBD gummies, softgels, and mints available to buy online.
  • Jason Peterson, Head of Brand, says, "We're delighted to launch Cycling Frog and our THC & CBD seltzers.
  • "With our products, we're hoping to change an entire generation's perception and access to THC & CBD products.

Robinson Pharma, Inc. Opens Its 8th and 9th Buildings in Santa Ana, California

Retrieved on: 
Wednesday, February 16, 2022
Tablet, Capsule, Dietary supplement, UL, NSF, Powder, Compliance, Softgel, CGMP, Good manufacturing practice, GLOBE, RPI, Eurofins Scientific

SANTA ANA, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Robinson Pharma, Inc. ("RPI") is pleased to announce two of its newest building acquisitions.

Key Points: 
  • SANTA ANA, Calif., Feb. 16, 2022 (GLOBE NEWSWIRE) -- Robinson Pharma, Inc. ("RPI") is pleased to announce two of its newest building acquisitions.
  • These new Santa Ana, California facilities will bring Robinson Pharma Inc. to nine state-of-the-art buildings to date, totaling over 1 million square feet combined.
  • The newly acquired buildings will provide support to fuel RPI's continuing business growth.
  • We understand your unique challenges as a business growing in the health/nutrition industry, and we believe that your success is our success.Come grow with us!